Exclusive preview of new BPM range that screens for underlying conditions using AI-powered algorithm

The annual ESC Congress is one of the most important gatherings for the global cardiology community, bringing together medical professionals, healthtech providers, and other allied professions to discuss the latest research and advances in the field. The 2025 edition, at IFEMA Madrid, will once again see OMRON Healthcare participating as both exhibitor and sponsor, continuing its longstanding association with this important congress. 

Following last year’s well-received OMRON Healthcare-sponsored symposium on atrial fibrillation and hypertension at ESC Congress 2024 in London, this year will see Omron Healthcare gather leading experts to sponsor a session entitled Unveiling the Hidden Threat: Recognizing Undiagnosed Heart Failure in Women. Taking place in IFEMA’s Sofia conference room from 15:15 on August 29, the symposium will include presentations by Alta Schutte from Australia’s George Institute for Global Health, Eva Gerdts from the University of Bergen in Norway, and Renate B. Schnabel from the University Heart and Vascular Centre Hamburg in Germany.

Despite being the leading cause of death for women globally, cardiovascular disease is frequently underdiagnosed and undertreated in women due to longstanding biases in research, clinical guidelines, and symptom recognition. A 2023 study conducted in Japan by OMRON Healthcare found that while 50% of women surveyed had experienced early warning signs such as palpitations and shortness of breath, more than half had not sought medical advice, with many dismissing their symptoms as signs of menopause.

The study also found that while around half of respondents had heard of atrial fibrillation (commonly known as AFib, a common type of arrhythmia whose impacts can include symptoms such as palpitations, shortness of breath, and fatigue, as well as clot formation in the atria, and even strokes), most were unaware of both the potential seriousness of the condition, and the importance of early detection and treatment to medium- and long-term health outcomes. 

OMRON Healthcare believes that a crucial tool in early diagnosis is regular self-measurement, using blood-pressure monitors that sync with the OMRON connect app to analyze patterns and facilitate data sharing with physicians, while leveraging the company’s unique Intellisense AFib technology to screen for symptoms of atrial fibrillation. As part of the company’s commitment to tackling such issues, the OMRON Healthcare booth at ESC Congress 2025 will provide attendees with an exclusive touch-and-try preview of a brand-new series of upper-arm blood pressure monitors that is scheduled for a global rollout later this year, with an AI-powered algorithm and other features that will be made available across the majority of OMRON Healthcare’s BPM portfolio. 

“We are thrilled to be back at ESC Congress again this year,” said Karen Benegmos-Sanders, Managing Director for OMRON Healthcare Europe. “And as well as gathering leading experts for a satellite symposium that addresses some crucial issues for the cardiovascular care sector, we are excited to provide an advance preview of our new upper-arm BPM series, which we believe has the potential to transform heart-health outcomes worldwide through the promotion of at-home monitoring, along with our proprietary screening technologies.”

Title

Unveiling the hidden threat: recognising undiagnosed heart failure in women

Date/Time

Friday, August 29, 15:15-16:00

Venue

Sofia conference room (North Convention Center)

Presentations/Speakers

Bias in cardiovascular care: why is cardiovascular disease often missed in women?
Speaker: Alta Schutte, The George Institute for Global Health, Sydney, Australia 

Risks and symptoms female heart failure
Speaker: Eva Gerdts, University of Bergen, Bergen, Norway

How early detection of atrial fibrillation can improve patient outcome
Speaker: Renate B Schnabel, University Heart and Vascular Centre Hamburg, Hamburg, Germany

For additional information on Omron Healthcare’s satellite symposium, visit the ESC Congress 2025 Scientific Programme.

Mission & Vision

Committed to advancing health and empowering people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision “Going for Zero, Preventive Care for the Health of Society,” the company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients reduce cerebro-cardiovascular events, aggravation of respiratory diseases, and restrictions due to chronic pain.

With well over 350 million units sold globally, OMRON provides the world’s most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has striven to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, providing products and services in over 130 countries.

OMRON Healthcare Group is headquartered in Kyoto, Japan.

For more information please visit

Website
https://www.omron-healthcare.com/ 

For professionals
https://www.omron-healthcare.com/professional

LinkedIn
https://www.linkedin.com/company/omron-healthcare-europe/

Media enquiries

This press release is disseminated by Kyodo PR on behalf of OMRON Healthcare.

For more information or for interview opportunities, please contact OMRON Healthcare Press Desk
omronhealthcare-pr@kyodo-pr.co.jp